Anti-androgenic effects of flavonols in prostate cancer

Tristan Boam1

  • 1Royal Liverpool University Hospital, Prescot Street, Liverpool, Merseyside, L7 8XP, UK.

Ecancermedicalscience
|November 12, 2015
PubMed

Insights

Flavonoids show promise for prostate cancer (PCa) chemoprevention. These compounds, including quercetin and fisetin, may target the androgen receptor (AR) axis, offering a safer approach for PCa treatment.

Area of Science:

  • Oncology
  • Nutritional Science
  • Molecular Biology

Background:

  • Dietary flavonoids are explored for prostate cancer (PCa) chemoprevention due to their safety.
  • Agents targeting the androgen receptor (AR) axis are crucial for castrate-resistant PCa (CRPC).

Purpose of the Study:

  • To review the chemopreventive potential of four major flavonols (quercetin, myricetin, kaempferol, fisetin) in PCa.
  • To explore the mechanisms by which flavonols may act on the AR axis in PCa models.

Main Methods:

  • Laboratory studies investigating flavonol efficacy in PCa models (castrate-sensitive and castrate-resistant).
  • Analysis of proposed mechanisms of flavonol action on the AR axis.

Main Results:

  • Four key flavonols demonstrated chemopreventive action in both PCa models.
  • Proposed mechanisms include 5α-reductase inhibition, androgen competition, AR complex suppression, and coregulator modulation (c-Jun, Sp1, PI3K/Akt pathway).

Conclusions:

  • Flavonols exhibit chemopreventive potential against PCa.
  • While AR axis modulation is a proposed mechanism, further evidence is needed to confirm its full contribution to flavonol efficacy.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.7K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
68
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K